Advac Therapeutic LLC
Phoenixville, PA · Biotech · Private
miRNA-mimic therapeutic delivered via liposomes to promote airway epithelial regeneration in acute lung injury
- Grants
- $2.1M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Small-molecule combinationsexpand hematopoietic stem cell ex vivo and in vivo | $203,101 | |
| Federal grant | Department of Health and Human Services · Phase I · Small-molecule combinationsexpand hematopoietic stem cell ex vivo and in vivo | $203,302 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $583,152 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $296,926 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of recombinant VSV vaccines for emerging bunyaviruses | $255,454 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $286,226 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of recombinant VSV vaccines for emerging bunyaviruses | $276,715 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2231 | Tenvie | — | — |
| 2232 | MITO-BIOTHERAPEUTICS, INC. | — | — |
| 2233 | CREEGH PHARMACEUTICALS INC | — | $500K |
| 2234 | Advac Therapeutic LLC | — | — |
| 2235 | I Peace, Inc. | — | $47M |
| 2236 | L.E.A.F. Pharmaceuticals LLC | — | $40M |
| 2237 | LOXIGEN, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.